Abstract. This study charted 237 fatal cases of bovine respiratory disease (BRD) observed from

No abstract

The objective was to assess vaccination programs for calves in a Retained Ownership Program (ROP) and their effect on feedlot performance.

Ractopamine hydrochloride (RAC) is a β-adrenergic agonist approved for feeding during the last 28 to 42 d prior to cattle slaughter to improve feedlot performance and carcass characteristics. Three thousand crossbred yearling steers (527 ± 2.4 kg; AVG ± SD) were used in two periods to evaluate the effects of various RAC withdrawal times on feedlot performance, health, and carcass characteristics. In Period 1, 6 blocks of 30 pens totaling 1,500 steers were utilized, which was repeated for Period 2. In a randomized complete block design, cattle were assigned to 1 of 5 treatments consisting of 1) No RAC fed (CON), 2) 12-h RAC withdrawal (12-hRAC), 3) 2-d RAC withdrawal (2-dRAC), 4) 4-d RAC withdrawal (4-dRAC), and 5) 7-d RAC withdrawal (7-dRAC). Cattle were fed for a total of 62 d, and applicable treatments were supplemented with 30.0 ppm (dry matter basis) of RAC (average dose = 322 mg per steer per day) for 33 d at the end of the feeding period, corresponding to their respective withdrawal times. Initial body weight (BW) displayed a quadratic curve, with 2-dRAC and 4-dRAC withdrawal periods having the greatest BW. Accordingly, dry matter intake (DMI) responded quadratically (P = 0.034), with 2-dRAC and 4-dRAC treatments demonstrating the greatest DMI. No significant treatment differences (P ≥ 0.641) were observed in final live BW, average daily gain (ADG), or feed efficiency. Alternatively, when using a common dressing percentage to calculate live BW, cattle on RAC treatments exhibited 7.6 kg additional live BW (P < 0.001) compared to CON cattle. Furthermore, carcass-adjusted ADG and feed efficiency did not differ (P > 0.10) between RAC treatments but were improved compared to the CON treatment (P ≤ 0.002). Hot carcass weight (HCW) was on average 4.9 kg greater (P < 0.001) for RAC treatments vs. CON, and no differences were detected (P > 0.10) among RAC treatments. Within RAC treatments, carcass cutability responded quadratically (P ≤ 0.005) to withdrawal period, with the 2-dRAC and 4-dRAC treatments containing more Yield Grade 4 and 5 and fewer Yield Grade 1 and 2 carcasses than the other RAC treatments. On the basis of the results of this experiment, feeding RAC improves dressing percentage, HCW, and carcass-adjusted BW, ADG, and feed efficiency. Furthermore, extending the RAC withdrawal period to 7 d does not have a significant impact on cattle performance or health and has minimal effects on carcass characteristics.

Feedgrade chlortetracycline (CTC) and oxytetracycline (OTC) are approved for use in beef cattle diets for the control of bovine respiratory disease (BRD). The objectives of this experiment were to compare CTC and OTC, administered according to label, for the treatment of BRD in Holstein calves and to characterize the influence of tulathromycin metaphylaxis in combination with tetracycline treatment. Summer-placed Holstein steer calves (n = 6,800) were randomly assigned to one of four treatments (11 blocks; initial BW = 140 ± 18 kg) as they passed through the squeeze chute at initial processing in a commercial feedlot. Treatments consisted of: (i) CTC and tulathromycin metaphylaxis (CTC+TUL), (ii) OTC and tulathromycin metaphylaxis (OTC+TUL), (iii) tulathromycin metaphylaxis only (TUL), or (iv) CTC only (CTC). Cattle were fed for an average of 118 d. Tetracycline feeding was instituted based on visual assessment of the attending veterinarian in accordance with the veterinary feed directive. When applicable, CTC was fed as a top-dress at a rate of 4 g CTC·steer−1·d−1 for 5 consecutive days, beginning on 6 d on feed (DOF). Three 5-d pulses were delivered to CTC+TUL and CTC cattle, with a 48-h time lapse between pulses. Cattle on OTC+TUL were administered 4 g OTC·steer−1·d−1 as part of a complete diet for 14 consecutive days beginning on 10 DOF. Within the first 30 d of the feeding period, BRD first pulls were reduced (P = 0.001) for CTC+TUL, OTC+TUL, and TUL relative to CTC alone. Percentage of BRD first pulls and total morbidity were lowest (P = 0.001) for CTC+TUL across the feeding period, with OTC+TUL and TUL being intermediate, and CTC alone exhibiting the highest percentage. Death loss and railers were not influenced (P ≥ 0.58) by treatment. Dry matter intake was greater (P = 0.001) for CTC+TUL than all other treatments. Final BW and ADG were greatest for CTC+TUL, lowest for TUL alone, and intermediate for the remaining treatments (P < 0.05) on a deads-and-railers-out basis. Deads-and-railers-in ADG was greatest (P < 0.05) for CTC+TUL compared to all other treatments. Feed conversion was not influenced (P ≥ 0.22) by treatment. In the current study, supplementation of OTC in combination with tulathromycin metaphylaxis did not benefit health over tulathromycin alone. Results suggest that CTC in combination with tulathromycin metaphylaxis reduces morbidity in Holstein steers calves, which may lead to improved performance.